Fibrosix Inc.
- UEI
- HLLEW3GUYDM5
- CAGE
- 7TYZ5
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: quieting systemic hyper-inflammation (covid-19) | Division of Industrial Innovation | $256,000 | |
| Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice | National Cancer Institute | $302,500 |
Quick answers
What is Fibrosix Inc.'s UEI?
Fibrosix Inc.'s Unique Entity ID (UEI) in SAM.gov is HLLEW3GUYDM5.
What is Fibrosix Inc.'s CAGE code?
Fibrosix Inc.'s CAGE code is 7TYZ5.
Is Fibrosix Inc. registered in SAM.gov?
Fibrosix Inc.'s SAM.gov registration expired on February 7, 2023.
What is Fibrosix Inc.'s most recent federal award?
Fibrosix Inc.'s most recent federal grant award is Sbir phase i: quieting systemic hyper-inflammation (covid-19) (2035857), from Division of Industrial Innovation, on March 1, 2021.
On GovTribe
See Fibrosix Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors